Clinical Research Focus #23 December | Cromos Pharma
Clinical Research Focus. 23rd Edition Cromos Pharma’s CEO Reflections on ESMO 2023: A Glimpse into the Future of Oncology The European Society for Medical Oncology (ESMO) 2023 conference has left the global biotech and medical community abuzz with the latest groundbreaking developments in the field of oncology. This year’s conference showcased an array of promising reports and advancements that have Read more
Clinical Intelligence Report 6th edition November
Shining a Spotlight on Diabetes Awareness Month: The Vital Role of Clinical Trials In the global fight against the rampant rise of Type 2 Diabetes Mellitus (T2DM), awareness and proactive measures have become paramount. This chronic metabolic disorder, marked by impaired insulin action and elevated blood glucose levels, affects millions worldwide. As we observe Diabetes Awareness Month, it’s crucial to delve into the significance of clinical trials in Read more
Navigating the Challenging Biotech Funding Landscape | Cromos Pharma
Navigating the Challenging Biotech Funding Landscape Strategies to Conserve Resources and Accelerate Innovation The biotech industry stands at the forefront of scientific innovation, offering the promise of groundbreaking therapies that can transform healthcare. However, the journey from concept to commercialization is fraught with challenges, and securing funding has never been more demanding. In this article, we’ll explore a comprehensive set of Read more
Clinical Research Focus | 22nd Edition. November | Cromos Pharma
Clinical Research Focus. 22nd Edition Fit-for-Purpose Biotech – CRO Collaboration: The FSP Model In the evolving biotech landscape, the Functional Service Provider (FSP) model is a strategic alliance that offers biotech companies the ability to access specialized services and expertise in specific drug development areas. Unlike traditional outsourcing, FSP models bring a new level of flexibility, enabling biotech firms to Read more